Amrize Ltd (AMRZ) is a cutting-edge technology firm revolutionizing the digital health and wellness sector by leveraging advanced technologies and data-driven solutions to enhance healthcare delivery. Focused on improving patient outcomes and expanding healthcare accessibility, Amrize is committed to extensive research and development that caters to the escalating demand for scalable health innovations. Its strategic initiatives and robust product offerings position the company as a significant contributor to the transformation of modern healthcare systems, making it a compelling investment opportunity in an evolving market landscape.
| Revenue (TTM) | $11.91B |
| Gross Profit (TTM) | $3.02B |
| EBITDA | $2.82B |
| Operating Margin | -3.72% |
| Return on Equity | 10.10% |
| Return on Assets | 4.96% |
| Revenue/Share (TTM) | $21.54 |
| Book Value | $23.97 |
| Price-to-Book | 2.26 |
| Price-to-Sales (TTM) | 2.37 |
| EV/Revenue | 2.985 |
| EV/EBITDA | 12.82 |
| Quarterly Earnings Growth (YoY) | 3.60% |
| Quarterly Revenue Growth (YoY) | 4.70% |
| Shares Outstanding | $553.45M |
| Float | $492.93M |
| % Insiders | 7.30% |
| % Institutions | 54.52% |
Volatility is currently contracting